Age-Defying GenXers and Boomers Overlook One Vital Aspect
A recent survey conducted by Miracle-Ear, an Amplifon company, delved into the impact of hearing loss on the Gen X and Baby Boomer populations, aged 44 to 78. With data…
Flinn Foundation Study Identifies Bioscience Growth Areas in Greater Phoenix
A recent study of Phoenix’s bioscience ecosystem has pinpointed three areas poised for significant growth and global impact, centered around the Phoenix Bioscience Core and surrounding regional hubs of research…
Ideal Living Expands to Europe with Health Optimisation Summit Appearance
Ideal Living, known for its AmazingAir and AquaTru products, will be showcasing at the Health Optimisation Summit in London’s Business Design Centre from June 15-16. This global event gathers experts…
Leonard Green & Partners and Francisco Partners Team Up for RedSail Technologies’ Growth
RedSail Technologies, a top provider of pharmacy solutions, has received a strategic growth investment from Leonard Green & Partners (LGP). Additionally, Francisco Partners (FP), the company’s creator through the merging…
AVAVA Secures $35M to Expand Breakthrough Laser TechLaser TechAVAVA Secures $35M to Expand Breakthrough Laser Tech
AVAVA, Inc., a pioneering medical aesthetics platform company developing safe and effective image-guided intradermal laser products for all skin tones, has secured $35 million in new financing. AVAVA, Inc. has…
“Pfizer Updates Phase 3 Duchenne Muscular Dystrophy Gene Therapy Study”
“Pfizer’s Phase 3 Study on Duchenne Muscular Dystrophy Gene Therapy Falls Short of Primary Endpoint” Pfizer Inc. (NYSE: PFE) has reported that its CIFFREO Phase 3 trial, which evaluated the…
FDA Approves Augtyro™ for NTRK-Positive Solid Tumors
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Augtyro™ (repotrectinib) for treating adult and pediatric patients aged 12 and…
Nature Medicine: Agenus’ Immunotherapy Effective Against Rising Colorectal Cancer in Young Americans
Agenus has announced groundbreaking results from a clinical trial, published in Nature Medicine, showcasing the potential of a novel immunotherapy combination for treating microsatellite stable metastatic colorectal cancer (MSS mCRC),…
FARXIGA Approved for Pediatric Type-2 Diabetes in the US
AstraZeneca’s FARXIGA® (dapagliflozin) has received approval from the US Food and Drug Administration (FDA) for improving glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and older.…
Introducing Biograph Trinion by Siemens Healthineers: Advanced PET/CT Scanner for Enhanced Performance
Siemens Healthineers has introduced the Biograph Trinion, a cutting-edge positron emission tomography/computed tomography (PET/CT) scanner renowned for its high performance, energy efficiency, and wide-ranging clinical capabilities, all while maintaining a…
HCA Healthcare Foundation Grants $1 Million to Consortium of Florida Education Foundations, Announces HCA Healthcare
One of the nation’s foremost healthcare providers, HCA Healthcare, has announced a significant contribution from the HCA Healthcare Foundation. Over the next three years, the Foundation will donate $1 million…
UnitedHealthcare Commits $1.5 Million to Enhance School-Based Health Care Services Throughout Iowa
UnitedHealthcare Community & State of Iowa Allocates $1.5 Million to Enhance School-Based Mental Health Care Services UnitedHealthcare Community & State of Iowa has unveiled a $1.5 million investment aimed at…